Business

Announcement on the Voluntary Disclosure of Receiving Drug Registration Certificates for Sequiretic Acetate Injection and Agomelatine Tablets

Announcement on the Voluntary Disclosure of Receiving Drug Registration Certificates for Sequiretic Acetate Injection and Agomelatine Tablets

articleSinopep-allsino Bio Pharmaceutical Co., Ltd. Class AJuly 31, 20255/news/announcement-on-the-voluntary-disclosure-of-receiving-drug-registration-certificates-for-sequiretic-acetate-injection-and-agomelatine-tablets
Announcement on the Voluntary Disclosure of Receiving Drug Registration Certificates for Sequiretic Acetate Injection and Agomelatine Tablets

About this update from Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class A

Announcement on the Voluntary Disclosure of Receiving Drug Registration Certificates for Sequiretic Acetate Injection and Agomelatine TabletsThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class A